Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.04
Delayed Data
As of Jul 31
 +0.07 / +1.76%
Today’s Change
3.26
Today|||52-Week Range
6.28
+16.43%
Year-to-Date

Today’s Trading

Previous close3.97
Today’s open3.97
Day’s range3.94 - 4.09
Volume1,119,624
Average volume (3 months)2,591,928
Market cap$977.8M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-211.11%
Earnings growth (this year)-81.63%
Earnings growth (next 5 years)-45.30%
Revenue growth (last year)-54.58%
P/E ratioNM
Price/Sales20.62
Price/Book18.80

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.89+4.26%
DVAXDynavax Technologies...+0.19+0.65%
FLMLFlamel Technologies ...+0.04+0.17%
PDLIPDL BioPharma Inc+0.06+1.04%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$37.0M
Annual profit (last year)-$60.5M
Net profit margin-163.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
CFO
Jack Lief
SVP-Operations &
Head-Global Regulatory Affairs
Craig M. Audet
Corporate headquarters
San Diego, California

Forecasts